000 01344 a2200397 4500
005 20250512234017.0
264 0 _c19830415
008 198304s 0 0 eng d
022 _a0361-5960
040 _aNLM
_beng
_cNLM
100 1 _aCobb, W R
245 0 0 _aActivity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical explants of human tumors in the 6-day subrenal capsule assay.
_h[electronic resource]
260 _bCancer treatment reports
_cFeb 1983
300 _a173-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcenaphthenes
650 0 4 _aAlkaloids
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHarringtonines
_xtherapeutic use
650 0 4 _aHomoharringtonine
650 0 4 _aHumans
650 0 4 _aKidney
650 0 4 _aMice
650 0 4 _aNeoplasm Transplantation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aRibonucleotides
_xtherapeutic use
700 1 _aBogden, A E
700 1 _aReich, S D
700 1 _aGriffin, T W
700 1 _aKelton, D E
700 1 _aLePage, D J
773 0 _tCancer treatment reports
_gvol. 67
_gno. 2
_gp. 173-8
999 _c6824860
_d6824860